3D Printing-Based Polymer Nanocomposites for Cancer Treatment: Innovations and Perspectives

Three-dimensional (3D) printing-based polymer nanocomposites have emerged as a transformative platform in cancer treatment due to their precision and ability to incorporate multifunctional features. These materials integrate biocompatible polymers with nanoscale components to create multifunctional structures that enhance drug delivery, tissue repair, and diagnostics. By incorporating nanoparticles, they enable localized treatment and improved visualization for real-time monitoring—offering a unified platform for therapy and diagnosis. By incorporating agents like liposomes, dendrimers, or magnetic nanocarriers, they achieve controlled release and tumor-specific action while minimizing systemic toxicity. In tissue engineering, these nanocomposites provide scaffolds that mimic the extracellular matrix, promoting cell adhesion, proliferation, and differentiation to repair tissues. Advanced 3D printing techniques ensure high-resolution fabrication of complex geometries tailored to individual patient needs. Polymer nanocomposites have shown significant potential in imaging applications, offering enhanced contrast in diagnostic techniques like magnetic resonance imaging, computed tomography, and fluorescence imaging. Functional nanoparticles, including quantum dots and gold nanostructures, are embedded into 3D-printed constructs to facilitate real-time tumor visualization. This multifunctionality allows the integration of therapy and diagnostics, paving the way for theranostic platforms. Furthermore, the scalability of 3D printing makes it suitable for precision medicine. Challenges remain in optimizing material properties, ensuring biocompatibility, and scaling production.